MedPath

Lexent Bio, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

Terminated
Conditions
Neoplasms, Non-hematologic - Stage I-III
First Posted Date
2017-03-07
Last Posted Date
2019-08-14
Lead Sponsor
Lexent Bio, Inc.
Target Recruit Count
5
Registration Number
NCT03071809
Locations
🇺🇸

Alisa Williams, MD Inc, San Diego, California, United States

Detection of Tumor DNA in Blood Samples From Cancer Patients

Conditions
Cancer
Tumors
Interventions
Diagnostic Test: Blood test
First Posted Date
2014-11-11
Last Posted Date
2019-08-14
Lead Sponsor
Lexent Bio, Inc.
Target Recruit Count
500
Registration Number
NCT02288754
Locations
🇺🇸

Cancer Care Associates, Torrance, California, United States

© Copyright 2025. All Rights Reserved by MedPath